NM_001277115.2:c.8533C>G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_001277115.2(DNAH11):​c.8533C>G​(p.Arg2845Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00132 in 1,552,168 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0016 ( 1 hom., cov: 32)
Exomes š‘“: 0.0013 ( 0 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 2.42
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.007217258).
BP6
Variant 7-21748602-C-G is Benign according to our data. Variant chr7-21748602-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 359658.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=5}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00161 (245/152328) while in subpopulation AFR AF= 0.00322 (134/41574). AF 95% confidence interval is 0.00278. There are 1 homozygotes in gnomad4. There are 111 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.8533C>G p.Arg2845Gly missense_variant Exon 52 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.8533C>G p.Arg2845Gly missense_variant Exon 52 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
243
AN:
152208
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00318
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00126
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00117
AC:
249
AN:
212646
Hom.:
0
AF XY:
0.00106
AC XY:
123
AN XY:
116114
show subpopulations
Gnomad AFR exome
AF:
0.00294
Gnomad AMR exome
AF:
0.000909
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000287
Gnomad FIN exome
AF:
0.000195
Gnomad NFE exome
AF:
0.00164
Gnomad OTH exome
AF:
0.00184
GnomAD4 exome
AF:
0.00129
AC:
1800
AN:
1399840
Hom.:
0
Cov.:
30
AF XY:
0.00120
AC XY:
828
AN XY:
692040
show subpopulations
Gnomad4 AFR exome
AF:
0.00278
Gnomad4 AMR exome
AF:
0.000870
Gnomad4 ASJ exome
AF:
0.0000421
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000329
Gnomad4 FIN exome
AF:
0.000462
Gnomad4 NFE exome
AF:
0.00140
Gnomad4 OTH exome
AF:
0.00162
GnomAD4 genome
AF:
0.00161
AC:
245
AN:
152328
Hom.:
1
Cov.:
32
AF XY:
0.00149
AC XY:
111
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00322
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.00126
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00125
Hom.:
0
Bravo
AF:
0.00168
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00232
AC:
9
ESP6500EA
AF:
0.000966
AC:
8
ExAC
AF:
0.00126
AC:
152
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
May 10, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

BP4 -

Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

DNAH11: BP4 -

Sep 07, 2022
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Identified in the heterozygous state in two individuals with suspected primary ciliary dyskinesia, but a second DNAH11 variant was not identified and one of these individuals was also found to have variants in another gene (Andjelkovic et al., 2018; Olm et al., 2019); Identified in a family with recurrent congenital heart disease; however, zygosity was not specified and a second variant in the DNAH11 gene was not identified (Izarzugaza et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30300419, 31213628, 34768622, 32859249) -

Primary ciliary dyskinesia 7 Uncertain:2
Jan 31, 2020
Revvity Omics, Revvity
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 06, 2020
Genetics and Molecular Pathology, SA Pathology
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Primary ciliary dyskinesia Uncertain:1Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.36
.;.;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.33
N
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.0072
T;T;T
MetaSVM
Benign
-1.1
T
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-2.9
.;D;.
REVEL
Benign
0.030
Sift
Uncertain
0.0020
.;D;.
Vest4
0.26
MVP
0.16
ClinPred
0.037
T
GERP RS
1.5
Varity_R
0.12
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121908854; hg19: chr7-21788220; COSMIC: COSV99078092; COSMIC: COSV99078092; API